A study of non-responders for the treatment of age-related macular degeneration who switched therapy from bevacizumab to ranibizumab or vice versa
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
Most Recent Events
- 18 Dec 2015 New trial record